Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection
Authors:
Open Access
- 11 January 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12, 813240
Abstract
A novel coronavirus designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged and caused an outbreak of unusual viral pneumonia. Several reports have shown that cross-reactive antibodies against SARS-CoV-2 also exist in people unexposed to this virus. However, the neutralizing activity of cross-reactive antibodies is controversial. Here, we subjected plasma samples from SARS-CoV-2-unexposed elderly Korean people (n = 119) to bead-based IgG antibody analysis. SARS-CoV-2 S1 subunit-reactive IgG antibody analysis detected positive signals in some samples (59 of 119, 49.6%). SARS-CoV-2 receptor-binding domain (RBD)-reactive antibody levels were most significantly correlated with human coronavirus-HKU1 S1 subunit-reactive antibody levels. To check the neutralizing activity of plasma samples, the SARS-CoV-2 spike pseudotype neutralizing assay was used. However, the levels of cross-reactive antibodies did not correlate with neutralizing activity. Instead, SARS-CoV-2 pseudovirus infection was neutralized by some RBD-reactive plasma samples (n = 9, neutralization ≥ 25%, P ≤ 0.05), but enhanced by other RBD-reactive plasma samples (n = 4, neutralization ≤ -25%, P ≤ 0.05). Interestingly, the blood plasma groups with enhancing and neutralizing effects had high levels of SARS-CoV-2 RBD-reactive antibodies than the plasma group that had no effect. These results suggest that some SARS-CoV-2 RBD-reactive antibodies from pre-pandemic elderly people exert two opposing functions during SARS-CoV-2 pseudovirus infection. In conclusion, preformed RBD-reactive antibodies may have two opposing functions, namely, protecting against and enhancing viral infection. Analysis of the epitopes of preformed antibodies will be useful to elucidate the underlying mechanism.Keywords
Funding Information
- National Research Foundation of Korea (2021R1A2C3011211)
- Seoul National University
This publication has 24 references indexed in Scilit:
- Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severityScience, 2020
- Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humansScience, 2020
- Seasonal coronavirus protective immunity is short-lastingNature Medicine, 2020
- Lessons for COVID-19 Immunity from Other Coronavirus InfectionsImmunity, 2020
- Neutralizing Antibodies against SARS-CoV-2 and Other Human CoronavirusesTrends in Immunology, 2020
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibodyNature, 2020
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization AssaysViruses, 2020
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Methods for the determination of limit of detection and limit of quantitation of the analytical methodsChronicles of Young Scientists, 2011